In a recent study posted to the bioRxiv* preprint server, researchers designed an efficient vaccine design against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. Study: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback